Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 30;7(18):3046-3049.
doi: 10.3889/oamjms.2019.766. eCollection 2019 Sep 30.

Dermatoporosis - The Chronic Cutaneous Fragility Syndrome

Affiliations
Review

Dermatoporosis - The Chronic Cutaneous Fragility Syndrome

Uwe Wollina et al. Open Access Maced J Med Sci. .

Abstract

Dermatoporosis is an important clinical condition leading to chronic skin fragility. It can be separated into primary and secondary subtypes, with the latter induced by medical drugs and environmental factors. Dermatoporosis can be classified into 4 major stages with increasing morbidity and mortality with the advanced stages. Its aetiology has been related to the epidermal hyalusome. Dermatoporosis is a cause of mortality in the intensive care unit and should be known not only by a dermatologist but another medical speciality as well. Prevention is of major importance. Therapeutic options are limited but available.

Keywords: Bruises; Dermatoporosis; ICU; Skin ageing; Skin fragility; Wound healing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dermatoporosis stage I with pronounced skin atrophy and pigmentary changes
Figure 2
Figure 2
Dermatoporosis with advanced skin atrophy and Bateman purpura in a patient with bullous pemphigoid
Figure 3
Figure 3
Delayed wound healing after laceration in a 76-year-old male patient with Parkinson’s disease
Figure 4
Figure 4
Chronic deep dissecting hematoma of the lower leg leading to secondary ulcerations of the skin
Figure 5
Figure 5
Ulceration and delayed wound healing after removal of a saphenous vein graft for coronary artery bypass graft surgery

References

    1. Zouboulis CC, Ganceviciene R, Liakou AI, Theodoridis A, Elewa R, Makrantonaki E. Aesthetic aspects of skin aging, prevention, and local treatment. Clin Dermatol. 2019;37(4):365–372. https://doi.org/10.1016/j.clindermatol.2019.04.002. PMid:31345325. - PubMed
    1. Kaya G, Saurat JH. Dermatoporosis:a chronic cutaneous insufficiency/fragility syndrome Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology. 2007;215(4):284–94. https://doi.org/10.1159/000107621. PMid:17911985. - PubMed
    1. Mengeaud V, Dautezac-Vieu C, Josse G, Vellas B, Schmitt AM. Prevalence of dermatoporosis in elderly French hospital in-patients:a cross-sectional study. Br J Dermatol. 2012;166(2):442–3. https://doi.org/10.1111/j.1365-2133.2011.10534.x. PMid:21787367. - PubMed
    1. Kluger N, Impivaara S. Prevalence of and risk factors for dermatoporosis:a prospective observational study of dermatology outpatients in a Finnish tertiary care hospital. J Eur Acad Dermatol Venereol. 2019;33(2):447–450. https://doi.org/10.1111/jdv.15240. PMid:30198583. - PubMed
    1. Saurat JH, Mengeaud V, Georgescu V, Coutanceau C, Ezzedine K, Taïeb C. A simple self-diagnosis tool to assess the prevalence of dermatoporosis in France. J Eur Acad Dermatol Venereol. 2017;31(8):1380–1386. https://doi.org/10.1111/jdv.14240. PMid:28342195. - PubMed

LinkOut - more resources